LEMAITRE VASCULAR, INC.

LMAT ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009
Revenue $56.1M $50.9M
Cost of Revenue $14.3M $13.6M
Gross Profit $41.7M $37.3M
Gross Margin 74.4% 73.3%
Operating Expenses
Research & Development $5.5M $5.9M
SG&A Expense $10.5M $9.9M
Operating Income $4.0M $1.9M
Operating Margin 7.2% 3.8%
Interest Expense $5.0K $26.0K
Pretax Income $4.0M $2.2M
Income Tax Expense $-2.0M $617.0K
Net Income $6.0M $1.6M
Net Margin 10.7% 3.1%
EPS (Basic) $0.38 $0.10
EPS (Diluted) $0.37 $0.10
Shares Outstanding (Basic) 15.6M 15.7M
Shares Outstanding (Diluted) 16.1M 15.9M
Dividends Per Share
← Newer Page 3 of 3 Older →